Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-17 4:08 pm Purchase | 2026-08-17 | 13G | JASPER THERAPEUTICS INC NE JSPR | Velan Capital Investment Management LP | 3,363,347 9.900% | 13,800 (+0.41%) | Filing History |
| 2026-07-20 5:01 pm Purchase | 2026-07-16 | 13D | JASPER THERAPEUTICS INC NE JSPR | Velan Capital Investment Management LP | 3,349,547 9.880% | 681,152 (+25.53%) | Filing History |
| 2026-07-10 6:20 pm Sale | 2026-06-30 | 13G | JASPER THERAPEUTICS INC NE JSPR | Integrated Core Strategies (US) LLC | 486,933 1.700% | -1,142,080 (-70.11%) | Filing History |
| 2026-05-12 12:44 pm Sale | 2026-03-31 | 13G | JASPER THERAPEUTICS INC NE JSPR | Morgan Stanley MS | 1,333,420 4.800% | -636,365 (-32.31%) | Filing History |
| 2026-05-08 5:01 pm Sale | 2026-03-31 | 13G | JASPER THERAPEUTICS INC NE JSPR | Soleus Capital Master Fund, L.P. | 276,312 1.000% | -1,218,108 (-81.51%) | Filing History |
| 2026-05-08 1:53 pm Sale | 2026-03-31 | 13G | JASPER THERAPEUTICS INC NE JSPR | THE GOLDMAN SACHS GROUP, INC. GS | 128,862 0.500% | -1,635,986 (-92.70%) | Filing History |
| 2026-02-25 4:47 pm Purchase | 2026-02-18 | 13G | JASPER THERAPEUTICS INC NE JSPR | Integrated Core Strategies (US) LLC | 1,629,013 5.800% | 1,629,013 (New Position) | Filing History |
| 2026-02-18 5:29 pm Purchase | 2026-02-18 | 13D | JASPER THERAPEUTICS INC NE JSPR | Carlyle Group Inc. CG | 1,088,310 3.800% | 22,121 (+2.07%) | Filing History |
| 2026-02-12 10:33 am Purchase | 2025-12-31 | 13G | JASPER THERAPEUTICS INC NE JSPR | THE GOLDMAN SACHS GROUP, INC. GS | 1,764,848 6.300% | 1,764,848 (New Position) | Filing History |
| 2026-02-11 1:38 pm Purchase | 2025-12-31 | 13G | JASPER THERAPEUTICS INC NE JSPR | Morgan Stanley MS | 1,969,785 7.000% | 1,185,157 (+151.05%) | Filing History |
| 2026-01-26 3:29 pm Sale | 2026-01-23 | 13G | JASPER THERAPEUTICS INC NE JSPR | ACORN BIOVENTURES, L.P. | 1,486,492 5.300% | -300,000 (-16.79%) | Filing History |
| 2025-12-02 10:23 am Purchase | 2025-12-01 | 13G | JASPER THERAPEUTICS INC NE JSPR | ACORN BIOVENTURES, L.P. | 1,786,492 6.400% | 1,786,492 (New Position) | Filing History |
| 2025-11-14 5:22 pm Unchanged | 2025-09-30 | 13G | JASPER THERAPEUTICS INC NE JSPR | Qiming U.S. Healthcare Fund II, L.P. | 928,964 3.300% | 0 (Unchanged) | Filing History |
| 2025-11-14 12:18 pm Purchase | 2025-09-30 | 13G | JASPER THERAPEUTICS INC NE JSPR | T. Rowe Price Investment Management, Inc. | 2,057,612 7.100% | 2,057,612 (New Position) | Filing History |
| 2025-11-12 1:04 pm Purchase | 2025-09-30 | 13G | JASPER THERAPEUTICS INC NE JSPR | KINGDON CAPITAL MANAGEMENT L.L.C. | 1,324,845 4.700% | 559,845 (+73.18%) | Filing History |
| 2025-11-07 12:45 pm Purchase | 2025-09-30 | 13G | JASPER THERAPEUTICS INC NE JSPR | Morgan Stanley MS | 784,628 2.800% | 26,175 (+3.45%) | Filing History |
| 2025-09-23 5:07 pm Purchase | 2025-09-19 | 13D | JASPER THERAPEUTICS INC NE JSPR | Velan Capital Investment Management LP | 2,668,395 9.600% | 1,196,492 (+81.29%) | Filing History |
| 2025-08-06 4:46 pm Purchase | 2025-06-30 | 13G | JASPER THERAPEUTICS INC NE JSPR | Morgan Stanley MS | 758,453 5.000% | 758,453 (New Position) | Filing History |
| 2025-07-17 8:12 pm Sale | 2025-06-30 | 13G | JASPER THERAPEUTICS INC NE JSPR | BlackRock, Inc. BLK | 225,605 1.500% | -574,423 (-71.80%) | Filing History |
| 2025-07-11 12:30 pm Purchase | 2025-07-03 | 13G | JASPER THERAPEUTICS INC NE JSPR | KINGDON CAPITAL MANAGEMENT L.L.C. | 765,000 5.100% | 765,000 (New Position) | Filing History |